Body Prime

by Synergy · capsule · 90 capsules

  • On the market (NIH)
  • DSLD label 249491
  • Serving 3 capsules
  • 30 servings

Body Prime by Synergy lists 3 ingredients, 1 with an amount per serving of 3 capsules, such as 600 mg of magnesium; 2 sit inside a blend without their own amounts. Its current label entered the NIH Dietary Supplement Label Database on July 27, 2021.

What is in Body Prime?

Each row as the label prints it, per serving of 3 capsules. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

Body Prime: Supplement Facts rows against the market (DSLD label 249491, January 2026 release)
IngredientAmount% DVAmong products listing it
Magnesiumas Magnesium Oxide600 mg143%Magnesium in Body Prime against 14,003 products600 mg per serving; the middle half of products list 30 mg to 200 mg, the median 86 mg.UL 350 mgDV 420 mg600 mg

Higher than 99% of 14,003 products listing magnesium (median 86 mg). 1.7 times the adult UL a day.

Proprietary Blend1,050 mg
Apple fruit Pectinin the blend, no amount given
Prune fruit powderin the blend, no amount given

Source: NIH ODS Dietary Supplement Label Database, label 249491 (entered July 27, 2021), version 9.4.0. See the label on DSLD. Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

The rows in the top or bottom tenth of the products that list the same ingredient, and any above the adult upper limit at the most servings a day the directions give:

  • At 1 serving a day, the most its directions give, the label lists 600 mg of magnesium, 1.7 times the adult Tolerable Upper Intake Level.

The NIH database records one serving a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

The products whose ingredient lists overlap most with Body Prime's, rare ingredients counting for more.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
Recommendation: Take three capsules once daily. Digestive tracts vary, begin with fewer capsules and increase to the highest recommended dose as necessary in order to achieve digestive response.
Warnings
This bottle is sealed for your protection. Do not use if inner seal is missing or damaged.

Source: label statements in DSLD label 249491.

What else is on the label?

Other ingredients: Capsule, Magnesium Stearate.

How many labels does Body Prime have?

2 labels are on file under this name since April 23, 2020: other sizes, label designs and reformulations. The current one leads this page.

  1. Label 249491 (current) Entered July 27, 2021 · on the market · 90 capsules
  2. Label 217262 Entered April 23, 2020 · on the market · 30 capsules · UPC 3 30929 75021 7

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names Synergy Worldwide (distributor), Spanish Fork, UT. All Synergy products.

Where next?